New pill aims to reignite motivation in Parkinson's patients
Symptom relief
Recruiting now
This study tests an experimental drug called IRL757 in 75 people with Parkinson's disease who also have apathy (loss of interest or motivation). The main goal is to check if the drug is safe and tolerable over 12 weeks. Researchers will also see if it helps improve apathy symptom…
Phase: PHASE1, PHASE2 • Sponsor: Integrative Research Laboratories AB • Aim: Symptom relief
Last updated May 26, 2026 10:22 UTC